Nascent Nanoformulations as an Insight Into the Limitations of the Conventional Systemic Antifungal Therapies.
Sign Up to like & getrecommendations! Published in 2022 at "Current drug targets"
DOI: 10.2174/1389450124666221128122836
Abstract: More than 150 million people have significant fungal diseases that have a growing impact on health care and economic expenditures. The expansion of systemic fungal infections and invasive mycoses is being driven by an increase… read more here.
Keywords: nanoformulations insight; limitations conventional; fungal infections; antifungal therapies ... See more keywords